Skip to main content

The rockefeller university

Calendar of Events & Lectures

Displaying 4 of 3482 events.
Today
This Week

Thursday, October 16, 2025

Skin Stem Cells: Making and Repairing Tissues in Homeostasis and Injury

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Stem Cell Biology Seminars
Elaine Fuchs, Ph.D., Rebecca C. Lancefield Professor and head of the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University; investigator, Howard Hughes Medical Institute

The Brain in High Resolution: From Receptors to Synapses

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Kavli Neural Systems Institute
Olga Boudker, Ph.D., Professor, Weill Cornell Medicine
Aashish Manglik, Ph.D., Associate Professor, University of California San Francisco
Cathy Spangler, Ph.D., Postdoctoral Fellow, Oregon Health & Science University
Briar Bell, Ph.D., Postdoctoral Fellow, UT Health Houston

Reproducibility and Generalization of State-of-the-art scRNAseq Cell Type Annotation

| WEBINAR
Lectures and Symposia, Other Lectures and Symposia
Simona Critea, Ph.D., head of genomics data science and AI at the Hale Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute; group leader in data science and AI and senior research scientist, Harvard School of Public Health

Homeoboxes in the Nervous System

| CASPARY AUDITORIUM
Lectures and Symposia, Harvey Society
Oliver Hobert, Ph.D., professor of biological sciences, Columbia University; investigator, Howard Hughes Medical Institute

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Lipid Therapy: A Novel Therapeutic Strategy Utilizing Low-density Lipoproteins Against Cancer

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.

The Tapestry of Human Prenatal Immunity

| 105 ZRC, MSKCC, 417 E. 68TH ST.

Dysregulated Nucleic Acid Sensing and Type I Interferons in Chronic Inflammation.

| 301 WRB

News

Rockefeller startup aims to change the course of treatment for severe autoimmune diseases

Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.

Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent

The discovery could greatly improve patient experience and address supply shortages.

This immune circuit may protect the brain from Alzheimer's

A newly identified molecular pathway shifts microglia into a protective state, and may lead to Alzheimer's therapies that can reprogram the brain’s own immune defenses.

Room Reservation Calendar